What questions should I ask about a CLL clinical trial

Questions to Ask About a CLL Clinical Trial

Clinical trials can offer access to newer treatments and close medical monitoring. Here are important questions to help you understand what you're considering:

ABOUT THE TRIAL ITSELF

1. What is this trial testing?

• What new drug or treatment combination is being studied?
• How does it differ from standard CLL treatments?
• Why do researchers think this approach might work?

2. What stage is this trial in?

• Phase I (testing safety and dosage in small groups)
• Phase II (testing effectiveness and side effects)
• Phase III (comparing to standard treatment)
• This tells you how much is already known about safety and effectiveness

3. What are the trial's goals?

• Is it trying to improve response rates (how many people respond)?
• Is it trying to extend survival time?
• Is it trying to reduce side effects?

ABOUT YOUR SPECIFIC SITUATION

4. Why am I eligible for this trial?

• What are the inclusion criteria (requirements to join)?
• Do my specific CLL characteristics (like genetic mutations, prior treatments) make me a good fit?
• Are there any reasons I might not be eligible?

5. How does this trial fit my treatment status?

• Is this for newly diagnosed patients, or those who've had prior treatment?
• If I've had previous therapies, how many prior treatments can I have had?
• According to NCCN Guidelines, treatment history affects which trials are appropriate

ABOUT TREATMENT & MONITORING

6. What will the treatment involve?

• How is the drug given (pills, infusions, injections)?
• How often and for how long?
• What does a typical visit schedule look like?

7. What side effects should I expect?

• What are the most common side effects?
• What are the serious side effects I need to watch for?
• How are side effects managed?
• For example, if the trial involves venetoclax (a BCL2 inhibitor), NCCN Guidelines note that tumor lysis syndrome (TLS—a serious condition from cancer cells breaking down) requires careful monitoring and preventive measures

8. What happens if I have severe side effects?

• Can the dose be reduced?
• Can I stop the trial?
• What support is available?

ABOUT RESULTS & YOUR CARE

9. How will we know if the treatment is working?

• What tests will measure response (blood work, imaging)?
• How often will these be done?
• What counts as a "response"?

10. What happens after the trial ends?

• Can I continue the treatment if it's working?
• What's the plan if it's not working?
• Will I have access to the drug after the trial?

11. Who is my main contact if I have questions or problems?

• Get a specific person's name and phone number
• Know how to reach them after hours if needed

ABOUT LOGISTICS & RIGHTS

12. What are the time and travel commitments?

• How many visits per month?
• How long are visits?
• Is this at a location convenient for you?

13. Are there costs to me?

• Is the experimental drug free?
• Are tests and visits covered?
• What about travel or lodging if needed?

14. Can I withdraw from the trial?

• You can always leave a trial
• What happens to your care if you do?
• Will you still be followed by your oncologist?

15. How will my data be used?

• How is my information protected?
• Can I see the results when the trial is complete?
• Will my data be shared with other researchers?

RED FLAGS TO DISCUSS WITH YOUR DOCTOR

• The trial requires you to stop all other treatments immediately
• There's pressure to decide quickly without time to think
• The trial coordinator can't clearly explain what's being tested
• Your oncologist expresses concerns about the trial's fit for you

IMPORTANT CONTEXT FOR CLL TRIALS

According to NCCN Guidelines for CLL, newer treatment approaches being studied include:

• BTK inhibitors (like ibrutinib, acalabrutinib, pirtobrutinib) - these target a specific protein that helps cancer cells survive
• BCL2 inhibitors (like venetoclax) - these work differently by triggering cancer cell death
• Combination approaches - combining different drug types
• CAR T-cell therapy - using your own immune cells engineered to fight cancer
• Immunotherapy combinations - pairing checkpoint inhibitors with other drugs

The right trial for you depends on your specific CLL characteristics, prior treatments, and overall health.

BEFORE YOU DECIDE

Take the trial information home. Review it with:

• Your primary oncologist (even if they're not running the trial)
• A trusted family member or friend
• Your local CLL specialist if possible

Ask for written information about the trial, and don't feel rushed to decide. A good trial will welcome your questions and give you time to think.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.